Mary Lynn McPherson, PharmD, PhD, BCPS

Titles

Professor of Practice, Sciences, and Health Outcomes Research

Executive Director, Advanced Post-Graduate Education in Palliative Care

Executive Director, Graduate Studies in Palliative Care

School Affiliation

School of Pharmacy

Specialties

  • Pain and Palliative Care
  • Health Professions Education

About

Dr. McPherson has maintained a practice in both hospice and palliative care throughout her career. She teaches extensively in the School’s Doctor of Pharmacy (PharmD) program on pain management and end-of-life care, including didactic and experiential content. She also developed one of the first palliative care pharmacy residency programs in the United States and is executive program director of the School’s online graduate studies in palliative care, including a Master of Science, Doctor of Philosophy, and graduate certificates. Dr. McPherson currently serves as the first pharmacist selected for the board of the American Association of Hospice and Palliative Care and is a founding trustee and board member of the Society of Pain Management and Palliative Care Pharmacists. She has received many honors for her work, including the American Pharmacists Association Distinguished Achievement Award in Specialized Practice, the University System of Maryland Board of Regents Award for Excellence in Teaching, the University of Maryland, Baltimore’s Founders Week Teacher of the Year Award, the Maryland Society of Health-Systems Pharmacists W. Purdum Lifetime Achievement Award, and the Robert K. Chalmers Distinguished Pharmacy Educator Award from the American Association of Colleges of Pharmacy. She has written five books, including the best-selling Demystifying Opioid Conversion Calculations, A Guide to Effective Dosing, 2nd ed.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: The Future of Health Care   Caring for the Human Condition   Research and Innovation  

This information was last updated February 16, 2024.